FAQ/Help |
Calendar |
Search |
Today's Posts |
06-19-2013, 08:24 AM | #1 | ||
|
|||
Magnate
|
Safinamide Phase III Study Results Presented at 2013 MDS Meeting
Read more here: http://www.sacbee.com/2013/06/18/550...#storylink=cpy |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 In | Parkinson's Disease | |||
Dyskinesias Study Results from Phase 1/2 NP002 in the Treatment of | Parkinson's Disease Clinical Trials | |||
Dyskinesias Study Results from Phase 1/2 NP002 | Parkinson's Disease | |||
Safinamide..Merck Serono Announces 18-Month Safety and Efficacy Data Phase III Trial | Parkinson's Disease Clinical Trials | |||
Phase III Data on Safinamide | Parkinson's Disease |